Search For

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy

Immune microenvironment and immunotherapy strategies in MAFLD-related hepatocellular carcinoma

Influence of the gut microbiota on the response to immunotherapy in hepatocellular carcinoma

Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article

Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Emerging data on immune checkpoint inhibitors in the neoadjuvant and adjuvant setting for patients with hepatocellular carcinoma

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma